JEFFREY MAZLIN
NEW YORK, NY NPI 1346288693
Browse related groups: NY Astellas Pharma US Inc All categories
General Payments — all program years on this page
$3,431.09
- Category: General Payments
- Program years: PY2018–2024
- Record count: 133
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $216.21 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $216.21 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $83.41 | 3 |
| MAYNE PHARMA COMMERCIAL LLC | $58.29 | 2 |
| Daiichi Sankyo Inc. | $26.26 | 1 |
| Biogen, Inc. | $24.89 | 1 |
| Agile Therapeutics, Inc. | $23.36 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1089453918 | Daiichi Sankyo Inc. | $26.26 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104813593 | Biogen, Inc. | $24.89 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139325036 | Astellas Pharma US Inc | $30.64 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139325188 | Astellas Pharma US Inc | $30.96 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139325246 | Astellas Pharma US Inc | $21.81 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154710955 | MAYNE PHARMA COMMERCIAL LLC | $26.53 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154710977 | MAYNE PHARMA COMMERCIAL LLC | $31.76 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154843117 | Agile Therapeutics, Inc. | $23.36 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.